Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults (clinicaltrials.gov) - Aug 25, 2023 - P3 | N=0 | Withdrawn | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd | N=600 ➔ 0 | Trial completion date: Sep 2024 ➔ Aug 2023 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Aug 2024 ➔ Aug 2023
Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • Infectious Disease • Novel Coronavirus Disease
|